| Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients R Cervera, JC Piette, J Font, MA Khamashta, Y Shoenfeld, MT Camps, ... Arthritis & Rheumatism: Official Journal of the American College of …, 2002 | 2565 | 2002 |
| Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients R Cervera, R Serrano, GJ Pons-Estel, L Ceberio-Hualde, Y Shoenfeld, ... Annals of the rheumatic diseases 74 (6), 1011-1018, 2015 | 1099* | 2015 |
| Low-molecular-weight heparin versus low-dose aspirin in women with one fetal loss and a constitutional thrombophilic disorder JC Gris, E Mercier, I Quéré, G Lavigne-Lissalde, E Cochery-Nouvellon, ... Blood 103 (10), 3695-3699, 2004 | 570 | 2004 |
| Effect of a retrievable inferior vena cava filter plus anticoagulation vs anticoagulation alone on risk of recurrent pulmonary embolism: a randomized clinical trial P Mismetti, S Laporte, O Pellerin, PV Ennezat, F Couturaud, A Elias, ... Jama 313 (16), 1627-1635, 2015 | 504 | 2015 |
| Superficial venous thrombosis and venous thromboembolism: a large, prospective epidemiologic study H Decousus, I Quéré, E Presles, F Becker, MT Barrellier, M Chanut, ... Annals of internal medicine 152 (4), 218-224, 2010 | 437 | 2010 |
| Case-control study of the frequency of thrombophilic disorders in couples with late foetal loss and no thrombotic antecedent JC Gris, I Quéré, F Monpeyrou, E Mercier, S Ripart-Neveu, ML Tailland, ... Thrombosis and haemostasis 81 (06), 891-899, 1999 | 301 | 1999 |
| Pharmacological agents targeting thromboinflammation in COVID-19: review and implications for future research B Bikdeli, MV Madhavan, A Gupta, D Jimenez, JR Burton, ... Thrombosis and haemostasis 120 (07), 1004-1024, 2020 | 287 | 2020 |
| ESVM Guideline on peripheral arterial disease U Frank, S Nikol, J Belch, V Boc, M Brodmann, PH Carpentier, A Chraim, ... Vasa, 2019 | 275 | 2019 |
| Addition of enoxaparin to aspirin for the secondary prevention of placental vascular complications in women with severe pre-eclampsia JC Gris, C Chauleur, N Molinari, P Marès, P Fabbro-Peray, I Quere, ... Thrombosis and haemostasis 106 (12), 1053-1061, 2011 | 223* | 2011 |
| Prospective evaluation of the prevalence of haemostasis abnormalities in unexplained primary early recurrent miscarriages JC Gris, S Ripart-Neveu, C Maugard, ML Tailland, S Brun, C Courtieu, ... Thrombosis and haemostasis 77 (06), 1096-1103, 1997 | 215 | 1997 |
| Antiphospholipid and antiprotein syndromes in non-thrombotic, non-autoimmune women with unexplained recurrent primary early foetal loss JC Gris, I Quéré, M Sanmarco, B Boutiere, E Mercier, J Amiral, AM Hubert, ... Thrombosis and haemostasis 84 (08), 228-236, 2000 | 177 | 2000 |
| A woman with five consecutive fetal deaths: case report and retrospective analysis of hyperhomocysteinemia prevalence in 100 consecutive women with recurrent miscarriages I Quere, H Bellet, M Hoffet, C Janbon, P Mares, JC Gris Fertility and sterility 69 (1), 152-154, 1998 | 176 | 1998 |
| Nailfold videocapillaroscopic features and other clinical risk factors for digital ulcers in systemic sclerosis: a multicenter, prospective cohort study M Cutolo, AL Herrick, O Distler, MO Becker, E Beltran, P Carpentier, ... Arthritis & rheumatology 68 (10), 2527-2539, 2016 | 162 | 2016 |
| Comparison of the clinical history of symptomatic isolated distal deep‐vein thrombosis vs. proximal deep vein thrombosis in 11 086 patients JP Galanaud, S Quenet, K Rivron‐Guillot, I Quere, JFS Munoz‐Torrero, ... Journal of Thrombosis and Haemostasis 7 (12), 2028-2034, 2009 | 154 | 2009 |
| IN FOCUS: Factor V Leiden and prothrombin G20210A polymorphisms as risk factors for miscarriage during a first intended pregnancy: the matched case–control ‘NOHA first’study G Lissalde-Lavigne, P Fabbro-Peray, E Cochery-Nouvellon, E Mercier, ... Journal of Thrombosis and Haemostasis 3 (10), 2178-2184, 2005 | 153 | 2005 |
| Antiphospholipid/antiprotein antibodies, hemostasis-related autoantibodies, and plasma homocysteine as risk factors for a first early pregnancy loss: a matched case-control study JC Gris, TV Perneger, I Quéré, E Mercier, P Fabbro-Peray, ... Blood 102 (10), 3504-3513, 2003 | 142 | 2003 |
| Comparative incidence of a first thrombotic event in purely obstetric antiphospholipid syndrome with pregnancy loss: the NOH-APS observational study JC Gris, S Bouvier, N Molinari, JP Galanaud, E Cochery-Nouvellon, ... Blood, The Journal of the American Society of Hematology 119 (11), 2624-2632, 2012 | 138 | 2012 |
| Red blood cell methylfolate and plasma homocysteine as risk factors for venous thromboembolism: a matched case-control study I Quéré, TV Perneger, J Zittoun, H Bellet, JC Gris, JP Daurès, JF Schved, ... The Lancet 359 (9308), 747-752, 2002 | 137 | 2002 |
| Euro-Phospholipid Project Group: Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients R Cervera, JC Piette, J Font, MA Khamashta, Y Shoenfeld, MT Camps, ... Arthritis Rheum 46 (4), 1019-1027, 2002 | 125 | 2002 |
| High frequency of protein Z deficiency in patients with unexplained early fetal loss JC Gris, I Quéré, H Dechaud, E Mercier, C Pinçon, M Hoffet, M Vasse, ... Blood, The Journal of the American Society of Hematology 99 (7), 2606-2608, 2002 | 124 | 2002 |
Pascale FabbroMCU-PH Epidémiologie Santé Publique - Université Montpellier- Faculté de MédecineAdresse e-mail validée de umontpellier.fr
